Jeffrey S Borgman

DDS | Dentist



  
  3203 N Macarthur Blvd, Irving
  Texas, 75062-4457

  972-258-1617    972-258-8540 Maps & Directions
Jeffrey S Borgman is a Irving, Texas based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 3203 N Macarthur Blvd, Irving. Patients can reach him at 972-258-1617.
Jeffrey S Borgman is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Jeffrey S Borgman speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Jeffrey S Borgman
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:3203 N Macarthur Blvd, Irving,
Texas, 75062-4457
Phone:972-258-1617
Fax:972-258-8540
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 4688988223
Enrollment ID: I20150727002867
NPI Number: 1689783664
NPI Enumeration Date: 30 Aug, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 3203 N Macarthur Blvd,
Irving, Texas
Zip: 75062-4457
Phone Number: 972-258-1617
Fax Number: 972-258-8540
Patients can reach Jeffrey S Borgman at 3203 N Macarthur Blvd, Irving, Texas or can call to book an appointment on 972-258-1617. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: